{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:06:19Z","timestamp":1790417179106,"version":"4.1.0"},"reference-count":191,"publisher":"Japan Atherosclerosis Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2002]]},"DOI":"10.5551\/jat.9.1","type":"journal-article","created":{"date-parts":[[2011,6,16]],"date-time":"2011-06-16T13:45:32Z","timestamp":1308231932000},"page":"1-27","source":"Crossref","is-referenced-by-count":165,"title":["Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults"],"prefix":"10.5551","volume":"9","author":[{"given":"Yoshiya","family":"Hata","sequence":"first","affiliation":[{"name":"Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mabuchi","sequence":"additional","affiliation":[{"name":"Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Saito","sequence":"additional","affiliation":[{"name":"Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Itakura","sequence":"additional","affiliation":[{"name":"Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genshi","family":"Egusa","sequence":"additional","affiliation":[{"name":"Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ito","sequence":"additional","affiliation":[{"name":"Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamio","family":"Teramoto","sequence":"additional","affiliation":[{"name":"Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoo","family":"Tsushima","sequence":"additional","affiliation":[{"name":"Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Tada","sequence":"additional","affiliation":[{"name":"Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Oikawa","sequence":"additional","affiliation":[{"name":"Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Yamada","sequence":"additional","affiliation":[{"name":"Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuya","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagahiko","family":"Sakuma","sequence":"additional","affiliation":[{"name":"Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","unstructured":"(1) Tarui S: Annual report of research committee on primary hyperlipidemia (Ministry of Health and Welfare), 1986"},{"key":"2","unstructured":"(2) Fukuda Y, Hayashi T, Komazawa T, Kusano S, and Hashimoto T: Incidence of cerebral apoplexy and heart attack through combined factors. Kokuteshu Chuo Hoken Kanrishoho, 9: 127-140, 1985 (in Japanese)"},{"key":"3","doi-asserted-by":"crossref","unstructured":"(3) Konishi M, Iida M, Naito Y, Terao A, Kiyama M, Kojima S, Shimamoto T, Doi M, and Komachi Y: Studies on the relationship between the trend of serum total cholesterol level and the incidence of cerebro-cardio-vascular diseases based on the follow-up studies in Akita and Osaka. With a special reference to the optimal serum total cholesterol level. Domyaku Koka, 15: 1115-1123, 1987 (in Japanese)","DOI":"10.5551\/jat1973.15.5_1115"},{"key":"4","doi-asserted-by":"crossref","unstructured":"(4) Kodama K, Sasaki H, and Shimazu Y: Trend of coronary heart disease and its relationship to risk factors in a Japanese population: A 26-year follow up, Hiroshima\/Nagasaki Study. Jpn Circ J, 54: 414-421, 1990","DOI":"10.1253\/jcj.54.414"},{"key":"5","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1161\/01.CIR.89.6.2533","volume":"89","year":"1994","unstructured":"(5) Kitamura A, Iso H, Naito Y, Iida M, Konishi M, Folsomv AR, Sato S, Kiyama M, Nakamura M, Sankai T, Shimamoto T, and Komachi Y: High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation, 89: 2533-2539, 1994","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"6","unstructured":"(6) The Japanese Association of Circulatory Disease Control: National survey of circulatory disease in 1980. Report on prospective survey: 35-81, 1995 (in Japanese)"},{"key":"7","doi-asserted-by":"crossref","unstructured":"(7) Gordon T, Kannel WB, Castelli WP, and Dawber TR: Lipoproteins, cardiovascular disease, and death: The Framingham study, Arch Intern Med, 141: 1128-1131, 1981","DOI":"10.1001\/archinte.141.9.1128"},{"key":"8","doi-asserted-by":"crossref","unstructured":"(9) Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the Pooling Project. J Chronic Dis, 31: 201-306, 1978","DOI":"10.1016\/0021-9681(78)90073-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"(10) Keys A: Seven Countries: A multivariate analysis of death and coronary heart disease, pp. 381, Cambridge, Mass, Harvard University Press, 1980","DOI":"10.4159\/harvard.9780674497887"},{"key":"10","unstructured":"(11) Ministry of Health and Welfare Health Service Bureau: General status of the 4<SUP>th<\/SUP> survey of circulatory diseases (1990). Japanese committee of management and research for circulation diseases. 1993"},{"key":"11","doi-asserted-by":"crossref","unstructured":"(12) The Expert Panel: Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med, 148: 36-69, 1988","DOI":"10.1001\/archinte.1988.00380010040006"},{"key":"12","doi-asserted-by":"publisher","unstructured":"(13) National Cholesterol Education Program Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation, 89: 1333-1445, 1994","DOI":"10.1161\/01.CIR.89.3.1333"},{"key":"13","unstructured":"(14) Study Group of the European Atherosclerosis Society: Strategies for the prevention of coronary heart disease. Eur Heart J, 8: 77-88, 1987"},{"key":"14","doi-asserted-by":"crossref","unstructured":"(15) Study Group of the European Atherosclerosis Society: The recognition and management of hyperlipidemia in adults. A policy statement of the European Atherosclerosis Society. Eur Heart J, 9: 571-600, 1988","DOI":"10.1093\/oxfordjournals.eurheartj.a062547"},{"key":"15","unstructured":"(16) Prevention of coronary heart disease: Scientific background and new clinical guidelines. Recommendations of the European Atherosclerosis Society prepared by the International Task Force for Prevention of Coronary Heart Disease. Nutr Metab Cardiovasc Dis, 2: 113-156, 1992"},{"key":"16","unstructured":"(17) Py&ouml;r&auml;l&auml; K, Backer D, Graham I, Poole-Wilson P, and Wood D (Members of the Task Force): Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J, 15: 1300-1331, 1994"},{"key":"17","unstructured":"(18) 1986 Winter Meeting abstracts of Japan Atherosclerosis Society 47: 1987"},{"key":"18","doi-asserted-by":"crossref","unstructured":"(19) Research Commitee on Serum Lipid Level Survey 1990 in Japan. Current state of and recent trends in serum lipid levels in the general Japanese population. J Atheroscler Thromb, 2: 122-132, 1996","DOI":"10.5551\/jat1994.2.122"},{"key":"19","unstructured":"(20) Health and Welfare Statistics Association: Annual statistical report of national health conditions, 42, 1995"},{"key":"20","doi-asserted-by":"crossref","unstructured":"(21) Friedewald WT, Levy RI, and Fredrickson D: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 18: 499-502, 1972","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"21","unstructured":"(22) Hata Y and Nakajima K: Applicability of the LDL-cholesterol level calculated by the Friedewald formula for serum lipids. Shishitu Seikagaku Kenkyu, 27: 123-126, 1972 (in Japanese)"},{"key":"22","unstructured":"(23) Tamada T and Iwasaki H: Age at natural menopause in Japanese women. Nippon Sanfujinka Zasshi, 47: 947-952, 1995 (in Japanese)"},{"key":"23","doi-asserted-by":"crossref","unstructured":"(24) Hiyamuta K, Toshima H, Koga Y, Nadayama H, Yamaga A, Shiraishi A, Maruyama H, Hidaka Y, Ueno T, Yoshiga O, Shibata J, Ikeda H, Tashiro H, Yoh M, and Harada K: Relationship between coronary risk factor and arteriographic feature of coronary atherosclerosis. Jpn Circ J, 54: 442-447, 1990","DOI":"10.1253\/jcj.54.442"},{"key":"24","unstructured":"(25) Ueda K: Changes in risk factor patterns for coronary heart disease over time: the Hisayama study. Nippon Junkanki Kanri Kenkyu Kyogikai Zasshi, 26: 155-160, 1992 (in Japanese)"},{"key":"25","unstructured":"(26) Ministry of Health and Welfare Health Service Bureau: Current status of national nutrition: Annual report of the nutritional research for national population (1993). Daiichi Press. 1995"},{"key":"26","doi-asserted-by":"crossref","unstructured":"(27) Guidelines Sub-committee of the WHO\/ISH Mild Hypertension Liasion Committee: 1993 Guidelines for the management of mild hypertension: memorandum from a WHO\/ISH meeting. J Hypertens, 11: 905-918, 1993","DOI":"10.1097\/00004872-199309000-00004"},{"key":"27","unstructured":"(28) Kosaka K, Akanuma Y, Goto Y, Hagura Y, Hirata Y, Kawate R, Kuzuya T, Mimura G, Nakayama H, Sakamoto N, and Shigeta Y: Committee&rsquo;s report for the diagnosis of diabetes mellitus. Tonyobyo, 25: 859-866, 1982 (in Japanese)"},{"key":"28","unstructured":"(29) Matsushima H, Yamasaki Y, Nisizawa H, Kodama M, Kubota M, Kawamori R, and Kamada T: Insulin resistance accelerates atherosclerosis in borderline diabetes. Tonyobyo 37; 88-894, 1994 (in Japanese)"},{"key":"29","first-page":"1373","volume":"I","year":"1980","unstructured":"(30) Fuller JH, Shipley MJ, Rose G, Jarrett RJ, and Keen H: Coronary heart disease risk factor and impaired glucose tolerance. The Whiterhall Study. Lancet, I: 1373-1376, 1980","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"30","unstructured":"(32) Ministry of Hearth and Welfare: Annual report of research committee on diabetes mellitus 1990"},{"key":"31","unstructured":"(33) Japanese Society of Obesity Committee for the guide of clinical treatment: Obesity and its related diseases. Guidebook for diagnosis, treatment and edcation. Ishiyaku Press, 1993"},{"key":"32","doi-asserted-by":"publisher","unstructured":"(34) Fujioka S, Matsuzawa Y, Tokunaga K, and Tarui S: Contribution of intraabdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism, 36: 54-59, 1987","DOI":"10.1016\/0026-0495(87)90063-1"},{"key":"33","unstructured":"(35) Kukita H, Tanaka R, Hiwada K, and Kokubu T: Lipoprotein particle size, protein-lipid composition abnormalities and coronary arteriosclerosis. Domyaku Koka, 14, 7-11, 1986 (in Japanese)"},{"key":"34","doi-asserted-by":"publisher","unstructured":"(36) Zilversmit DB: Atherosclerosis; a post plandial phenomenon. Circulation, 60: 473-485, 1979","DOI":"10.1161\/01.CIR.60.3.473"},{"key":"35","doi-asserted-by":"publisher","unstructured":"(37) Austin MA, King MC, Vranizan KM, and Krass RM: Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease. Circulation, 82: 495-506, 1990","DOI":"10.1161\/01.CIR.82.2.495"},{"key":"36","doi-asserted-by":"publisher","unstructured":"(38) Murai A, Miyahara T, Fujimoto N, Matsuda M, and Kameyama M: Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis, 59: 199-204, 1986","DOI":"10.1016\/0021-9150(86)90048-1"},{"key":"37","doi-asserted-by":"crossref","unstructured":"(39) Sasaki J and Mori T: Treatment guideline of hyperlipidemia with hypoHDLcholesterolemia associated with several risk factors (smoking, obesity, male, family history of ischemic heart disease). Domyaku Koka, 23: 627-630, 1996 (in Japanese)","DOI":"10.5551\/jat1973.23.10_627"},{"key":"38","doi-asserted-by":"crossref","unstructured":"(40) Criqui MI, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, and Browner D: Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med, 326: 381-386","DOI":"10.1056\/NEJM199202063260605"},{"key":"39","doi-asserted-by":"crossref","unstructured":"(41) Salonen JT and Salonen R: Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb, 11: 1245-1249, 1991","DOI":"10.1161\/01.ATV.11.5.1245"},{"key":"40","doi-asserted-by":"publisher","unstructured":"(42) Aoshima S, Bang HR, Masuda N, Tawarahara K, Taguchi T, Terada H, Kaneko M, Kurata C, Kobayashi A, Yamazaki N, Hachiya T, Koyano K, and Sakaguchi S: Coronary artery disease in patients with arteriosclerosis obliterans of the lower extremities or aortic aneurysm. Internal Medicine, 31: 994-997, 1992","DOI":"10.2169\/internalmedicine.31.994"},{"key":"41","doi-asserted-by":"crossref","unstructured":"(43) Shibuya T, Arakawa H, and Satomura K: Target levels for plasma lipids in patients with coronary artery disease. Domyaku Koka 23: 619-623, 1996 (in Japanese)","DOI":"10.5551\/jat1973.23.10_619"},{"key":"42","unstructured":"(44) Goldstein JL and Brown MS: Familial hypercholesterolemia. In: The Metabolic Basis of Inherited Disease. ed by Scriver CR, Beaudet AL, Sly WS, et al., pp 1215-1250, McGraw-Hill Book Co, New York, 1989"},{"key":"43","doi-asserted-by":"crossref","unstructured":"(45) Mabuchi H, Miyamoto S, Ueda K, Oota M, Takegoshi T, Wakasugi T, and Takeda R: Causes of death in patients with familial hypercholesterolemia. Atherosclerosis, 61: 1-6, 1985","DOI":"10.1016\/0021-9150(86)90107-3"},{"key":"44","doi-asserted-by":"crossref","unstructured":"(46) Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, and Motulsky AG: Hyperlipidemia in coronary heart disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest, 52: 1544-1568, 1973.","DOI":"10.1172\/JCI107332"},{"key":"45","unstructured":"(47) Uno Y and Mabuchi H: Disease analysis method and latest medical treatment. Concept of complex type hyperlipidemia. Lipid, 2: 373-379, 1991 (in Japanese)"},{"key":"46","doi-asserted-by":"crossref","unstructured":"(48) Sniderman A, Shapiro S, and Marpole D: Association of coronary atherosclerosis with hyperapo-betalipoproteinemia (increased protein but normal cholesterol levels in human plasma low density (B) lipoprotein). Proc Natl Acad Sci USA, 77: 604-608, 1980","DOI":"10.1073\/pnas.77.1.604"},{"key":"47","unstructured":"(49) Honda Y and Murase T: Hyperlipidemia and arteriosclerosis. Practice of diet therapy and exercise therapy. Medical Practice, 10: 2411-2416, 1993 (in Japanese)"},{"key":"48","unstructured":"(50) Matsubara H, Kojo Y, Shimada K, Yamada Y, Matsuda H, Uehara H, and Nakayama H: Studies on serum lipid metabolism disorder in the healthy aged: Changes and lipoprotein metabolism in the hypercholesterolemic patients following nutrition and exercise guidance in a year. Kosei Nenkin Byoin Nenpo, 14: 423-425, 1987 (in Japanese)"},{"key":"49","unstructured":"(51) Nakajima Y: On the life-care which influence on the serum concentration of total cholesterol and HDL-cholesterol. Arch Kohno Inst, 7: 101-104, 1991"},{"key":"50","unstructured":"(52) Yukawa K, Kato K, Oshita K, Inada K, Sato T, Tanaka Y, and Imanishi Y: Instruction on nutrition of a hyperlipidemia patient. The comparison with patient under combined use of exercise therapy. Rinsho Eiyo, 80: 277-281, 1992 (in Japanese)"},{"key":"51","unstructured":"(53) Adachi Y, Miyoshi E, Iwanaga M, Okuma C, Adachi A, and Yamagami T: Active health education for hypercholesterolemia and preservation of the result. Rinsho Eiyo, 82: 277-283, 1993 (in Japanese)"},{"key":"52","doi-asserted-by":"crossref","unstructured":"(54) Wittles EH, Hay JW, and Gotto AM Jr: Medical costs of coronary artery disease in the United States. Am J Cardiol, 65: 432-440, 1990","DOI":"10.1016\/0002-9149(90)90806-C"},{"key":"53","unstructured":"(55) Martens LL and Guibert R: Cost-effectiveness analysis of lipid-modifying therapy in Canada: Comparison of HMG-CoA reductase inhibitors in primary prevention of coronary heart disease. Clin Ther, 16: 1052-1062, 1994"},{"key":"54","first-page":"S30","volume":"69 Suppl 1","year":"1993","unstructured":"(56) Reckless JP: Cost-effectiveness of hyperlipidaemic drugs. Postgraduate Medical Journal, 69 (Suppl 1): S 30-33, 1993","journal-title":"Postgraduate Medical Journal","ISSN":"https:\/\/id.crossref.org\/issn\/0032-5473","issn-type":"print"},{"key":"55","doi-asserted-by":"publisher","unstructured":"(57) Hamilton VH, Racicot FE, Zowall H, Coupal L, and Grover SA: The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease: Estimating the benefits of increasing HDL-C. JAMA, 273: 1032-1038, 1995","DOI":"10.1001\/jama.273.13.1032"},{"key":"56","unstructured":"(58) Fujino S, Suzuki Y, Sato K, Imai H, and Akazawa T: Cost-effectiveness analysis of antihyperlipemic therapy in the prevention of coronary heart disease. -The case of pravastatin (A HMG-CoA reductase inhibitor). Rinsho Iyaku, 5: 461-490, 1989 (in Japanese)"},{"key":"57","doi-asserted-by":"crossref","unstructured":"(1) Farmer RG, et al.: Hyperlipoproteinemia and pancreatitis. Am J Med, 54: 161-165, 1973","DOI":"10.1016\/0002-9343(73)90219-2"},{"key":"58","unstructured":"(2) Brunzell JD: Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: The Metabolic Basis of Inherited Disease. ed. by Scriver CR, Beaudet AL, Sly WS and Valle D, 6th ed, pp. 1165-1180, McGraw Hill, NY, 1989"},{"key":"59","doi-asserted-by":"crossref","unstructured":"(3) Austin MA: Plasma triglyceride and coronary heart disease. Arterioscler Thromb, 11: 2-14, 1991","DOI":"10.1161\/01.ATV.11.1.2"},{"key":"60","doi-asserted-by":"crossref","unstructured":"(4) Austin MA and Hokanson JE: Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein (a) as risk factors for coronary heart disease. Med Clin North Am, 78: 99-115, 1994","DOI":"10.1016\/S0025-7125(16)30178-X"},{"key":"61","doi-asserted-by":"crossref","unstructured":"(5) Hamsten A: Hypertriglyceridemia, triglyceride-rich lipoproteins and coronary heart diseae. Balli&eacute;re&rsquo;s Clin Endocrinol Metab, 4: 895-922, 1990","DOI":"10.1016\/S0950-351X(05)80084-9"},{"key":"62","doi-asserted-by":"crossref","unstructured":"(6) Hulley SB, et al.: Epidemiology as a guide to clinical decisions: the asociation between triglyceride and coronary heart disease. N Engl J Med, 302: 1383-1389, 1980","DOI":"10.1056\/NEJM198006193022503"},{"key":"63","doi-asserted-by":"crossref","unstructured":"(7) Carlson LA, et al.: Reduction of mortality in the Stockholm Ischemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand, 223: 405-418, 1988","DOI":"10.1111\/j.0954-6820.1988.tb15891.x"},{"key":"64","doi-asserted-by":"crossref","unstructured":"(8) Freedman DS, et al.: Relation of triglyceride level to coronary artery disease: the Milwaukee Cardiovascular Data Registry. Am J Epidemiol, 127: 1118-1130, 1986","DOI":"10.1093\/oxfordjournals.aje.a114906"},{"key":"65","doi-asserted-by":"crossref","unstructured":"(9) Cambien F, et al.: Is the level of serum triglyceride a significant predictor of coronary death in normocholesterolemic subjects? The Paris Prospective Study. Am J Epidemiol, 124: 624-632, 1986","DOI":"10.1093\/oxfordjournals.aje.a114435"},{"key":"66","doi-asserted-by":"crossref","unstructured":"(10) Castelli WP: The triglyceride issue: a view from the Framingham. Am Heart J, 112: 432-437, 1986","DOI":"10.1016\/0002-8703(86)90296-6"},{"key":"67","doi-asserted-by":"crossref","unstructured":"(11) Rhoads GA, et al.: Serum triglyceride and risk of coronary heart disease, stroke and total mortality in Japanese American men. Atherosclerosis, 3: 316-322, 1983","DOI":"10.1161\/01.ATV.3.4.316"},{"key":"68","doi-asserted-by":"crossref","unstructured":"(12) Bath JD, et al.: Progression and regression of human coronary atherosclerosis. Atherosclerosis, 68: 51-58, 1987","DOI":"10.1016\/0021-9150(87)90093-1"},{"key":"69","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1161\/01.CIR.90.5.2230","volume":"90","year":"1994","unstructured":"(13) Drexel H, et al.: Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation, 90: 2230-2235, 1994","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"70","unstructured":"(14) Kukita H, et al.: Special issue: triglyceride and arteriosclerosis. Does hypertriglyceridaemia make progress of the arteriosclerosis? Hypertriglyceridaemia and arteriosclerosis observed epidemiologically. Lipid, 3: 390-396, 1992 (in Japanese)"},{"key":"71","doi-asserted-by":"crossref","unstructured":"(15) Patsch JR: Triglyceride-rich lipoproteins and atherosclerosis. Atherosclerosis, 110 (Suppl): s23-s26, 1994","DOI":"10.1016\/0021-9150(94)05372-P"},{"key":"72","doi-asserted-by":"crossref","unstructured":"(16) Zilversmit DB: Atherogenic nature of triglycerides, post-prandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem, 41: 153-158, 1995","DOI":"10.1093\/clinchem\/41.1.153"},{"key":"73","unstructured":"(17) Bradley WA and Gianturco SH: Triglyceride-rich lipoproteins and atherosclerosis: Pathophysiological consideration. J Intern Med, 236 (suppl 736): 33-39, 1994"},{"key":"74","doi-asserted-by":"crossref","unstructured":"(18) Research Committee on Serum Lipid Level Survey 1990 in Japan: Current state of and recent trends in serum lipid levels in the general Japanese population. J Atheroscler Thromb, 2: 122-132, 1996","DOI":"10.5551\/jat1994.2.122"},{"key":"75","unstructured":"(19) Study group of the Ministry of Education, Science, and Culture (Group leader: Oshima K): Study of serum cholesterol and triglyceride levels in the healthy Japanese population. Domyaku Koka Kenkyu Kaishi, 101-108, 1974 (in Japanese)"},{"key":"76","unstructured":"(20) Ministry of Health and Welfare Health Service Bureau: General status of the 4<SUP>th<\/SUP> survey of circulatory diseases (1990). Japanese committee of management and research for circulation diseases. 1993"},{"key":"77","doi-asserted-by":"crossref","unstructured":"(21) Kukita H, et al.: Plasma lipids and lipoproteins in Japanese male patients with coronary artery disease and in their relatives. Atherosclerosis, 42: 21-29, 1982","DOI":"10.1016\/0021-9150(82)90122-8"},{"key":"78","doi-asserted-by":"crossref","unstructured":"(22) Sekimoto H, et al.: Changes of serum total cholesterol and triglyceride levels in normal subjects in Japan in the past twenty years. Jpn Circ J, 47: 1351-1358, 1983","DOI":"10.1253\/jcj.47.1351"},{"key":"79","doi-asserted-by":"publisher","unstructured":"(23) Kukita H, et al.: Clinical significance of measurements of serum apolipoprotein A-I, A-II and B in hypertriglyceridemic male patients with and without coronary artery disease. Atherosclerosis, 55: 143-149, 1985","DOI":"10.1016\/0021-9150(85)90093-0"},{"key":"80","unstructured":"(24) Egusa G, et al.: Relationship between serum triglyceride value and arteriosclerotic heart disease. From an epidemiologic point of view. Therapeutic Research, 12: 544-549, 1991 (in Japanese)"},{"key":"81","unstructured":"(25) Kukita H, et al.: Neutral fats as a risk factor for arteriosclerosis. The 3rd triglyceride workshop record. Therapeutic research, 12: 552-557, 1991 (in Japanese)"},{"key":"82","unstructured":"(26) Tarui S: Hyperlipidemia and its complications among Japanese. Domyaku Koka, 18: 1-16, 1990 (in Japanese)"},{"key":"83","doi-asserted-by":"crossref","unstructured":"(27) Yoshino G. et al.: Recommendation for strict control of plasma triglyceride in diabetic subjects. Diabetic Care, 11: 794-795, 1988","DOI":"10.2337\/diacare.11.10.794"},{"key":"84","unstructured":"(28) Inada H, et al.: Diabetes mellitus and macroangiopathy. Epidemiology. Risk factor of NIDDM in Japan. Statistical analysis in multicenter cooperation clinical research (MSDM). Gendai Iryo, 27: 2669-2674, 1995 (in Japanese)"},{"key":"85","unstructured":"(29) Kukita H and Hiwada K: Hypertriglyceridemia as a risk factor for coronary artery disease. Therapeutic Research, 14: 551-558, 1993 (in Japanese)"},{"key":"86","doi-asserted-by":"crossref","unstructured":"(30) Goldstein JL, et al.: Hyperlipidemia in coronary heart disease: II. Genetic analysis in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest, 52: 1544-1568, 1973","DOI":"10.1172\/JCI107332"},{"key":"87","unstructured":"(31) Mahley RW, et al.: Lipoproteins of special significance in atherosclerosis: Insights provided by studies of Type III hyperlipidemia. Ann NY Acad Sci, 485: 209-221, 1986"},{"key":"88","doi-asserted-by":"crossref","unstructured":"(32) Brewer BH Jr, et al.: Type III hyperlipidemia: Diagnosis, molecular defects, pathology and treatment. Ann Intern Med, 98 (part 1): 623-640, 1983","DOI":"10.7326\/0003-4819-98-5-623"},{"key":"89","doi-asserted-by":"crossref","unstructured":"(33) Schaefer EJ, et al.: Familial lipoprotein disorders and premature coronary artery disease. Curr Opin Lipidol, 4: 288-298, 1993","DOI":"10.1097\/00041433-199308000-00005"},{"key":"90","doi-asserted-by":"publisher","unstructured":"(34) Brunzell JD, et al.: Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism, 25: 313-320, 1976","DOI":"10.1016\/0026-0495(76)90089-5"},{"key":"91","doi-asserted-by":"crossref","unstructured":"(35) Grundy SM: Atherogenic dyslipidemia: lipoprotein abnormalities and implications for therapy. Am J Cardiol, 75: 45B-52B, 1995","DOI":"10.1016\/0002-9149(95)80011-G"},{"key":"92","unstructured":"(36) Tada N: Remnant lipoproteins. Lipid, 7: 2-8, 1996 (in Japanese)"},{"key":"93","doi-asserted-by":"publisher","unstructured":"(37) Kameda K, et al.: Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan. Atherosclerosis, 51: 241-249, 1984","DOI":"10.1016\/0021-9150(84)90171-0"},{"key":"94","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2337\/diab.23.2.105","volume":"23","year":"1974","unstructured":"(38) Garcia MJ, et al.: Morbidity and mortality in diabetics in the Framingham population: Sixteen-year follow-up study. Diabetes, 23: 105-111, 1974","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"key":"95","first-page":"79","volume":"22","year":"1982","unstructured":"(39) Jarrett RJ, et al.: The Betford Survey: Ten-year mortality in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia, 22: 79-84, 1982","journal-title":"Diabetologia","ISSN":"https:\/\/id.crossref.org\/issn\/0012-186X","issn-type":"print"},{"key":"96","doi-asserted-by":"crossref","unstructured":"(40) Paker F, et al.: Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthomas: a correlative lipid biochemical histochemical and electron microscopic study. J Clin Invest, 49: 2172-2187, 1970","DOI":"10.1172\/JCI106436"},{"key":"97","doi-asserted-by":"crossref","unstructured":"(41) Witztum JL and Steinberg D: Role of oxidized low density lipoprotein in atherosclerosis. J Clin Invest, 881: 1785-1792, 1991","DOI":"10.1172\/JCI115499"},{"key":"98","doi-asserted-by":"crossref","unstructured":"(42) Gianturco SH, et al.: Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophage. J Clin Invest, 70: 168-178, 1982","DOI":"10.1172\/JCI110590"},{"key":"99","doi-asserted-by":"crossref","unstructured":"(43) Ishibashi S, et al.: Apolipoprotein E and lipoprotein lipase secreted from human monocyte-derived macrophages modulate very low density lipoprotein uptake. J Biol Chem, 265: 3040-3047, 1990","DOI":"10.1016\/S0021-9258(19)39730-3"},{"key":"100","doi-asserted-by":"crossref","unstructured":"(44) Lindqvist P, et al.: The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophage. J Biol Chem, 258: 9086-9092, 1983","DOI":"10.1016\/S0021-9258(17)44634-5"},{"key":"101","doi-asserted-by":"crossref","unstructured":"(45) Gianturco SH, et al.: Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins. J Clin Invest, 82: 1633-1643, 1988","DOI":"10.1172\/JCI113775"},{"key":"102","doi-asserted-by":"crossref","unstructured":"(46) Gianturco SH, et al.: Cellular binding site and membrane binding proteins for triglyceride-rich lipoproteins in human monocyte-macrophage and THP-1 monocyte cells. J Lip Res, 35: 1674-1687, 1994","DOI":"10.1016\/S0022-2275(20)41165-4"},{"key":"103","doi-asserted-by":"crossref","unstructured":"(47) Shimada M, et al.: Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. Proc Natl Acad Sci USA, 93: 7242-7246, 1996","DOI":"10.1073\/pnas.93.14.7242"},{"key":"104","doi-asserted-by":"publisher","unstructured":"(48) Welborn TA and Wearne K: Coronary heart disease incidence and cardiovascular mortality in Bisselton with reference to glucose and insulin concentration. Diabetes Care, 2: 154-160, 1979","DOI":"10.2337\/diacare.2.2.154"},{"key":"105","doi-asserted-by":"publisher","unstructured":"(49) Py&ouml;r&auml;l&auml; K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland. Diabetes Care, 2: 131-141, 1972","DOI":"10.2337\/diacare.2.2.131"},{"key":"106","doi-asserted-by":"crossref","unstructured":"(50) Lindahl B, et al.: High serum insulin, insulin resistance and their associations with cardiovascular risk factors. The northern Sweden Monica population study. J Intern Med, 234: 263-270, 1993","DOI":"10.1111\/j.1365-2796.1993.tb00742.x"},{"key":"107","doi-asserted-by":"crossref","unstructured":"(51) Frayn KN: Insulin resistance and lipid metabolism. Curr Opin Lipidol, 4: 197-204, 1993","DOI":"10.1097\/00041433-199306000-00004"},{"key":"108","doi-asserted-by":"crossref","unstructured":"(52) Nakamura T, et al.: Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis, 107-114, 1994","DOI":"10.1016\/0021-9150(94)90025-6"},{"key":"109","first-page":"1497","volume":"37","year":"1988","unstructured":"(53) Reaven GM: Role of insulin resistance in human disease. Diabetes, 37: 1497-1607, 1988","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"key":"110","doi-asserted-by":"crossref","unstructured":"(54) Kaplan NM: The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med, 149: 1514-1520, 1989","DOI":"10.1001\/archinte.1989.00390070054005"},{"key":"111","doi-asserted-by":"publisher","unstructured":"(55) DeFronzo RA, et al.: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14, 173-194, 1991","DOI":"10.2337\/diacare.14.3.173"},{"key":"112","doi-asserted-by":"crossref","unstructured":"(56) Despres J-P and Marette A: Relation of components of insulin resistance syndrome to coronary disease risk. Curr Opin Lipidol, 5: 274-289, 1994","DOI":"10.1097\/00041433-199408000-00006"},{"key":"113","unstructured":"(57) Takemura K and Matsuzawa Y: All of the triglyceride. Secondary hypertriglycemia. The obesity. Gendai Iryo, 28: 1781-1785,1996 (in Japanese)"},{"key":"114","first-page":"116","volume":"62.Suppl.IV","year":"1980","unstructured":"(58) Heiss, et al.: The epidemiology of plasma high-density lipoprotein cholesterol levels: the Lipid Research Clinics Program Prevalence Study. Circulation 62, (suppl IV) 116-136, 1980","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"115","doi-asserted-by":"crossref","unstructured":"(59) Magill P, et al.: Relationships between the metabolism of high-density and very low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity. Eur J Clin Invest, 12: 113-120, 1982","DOI":"10.1111\/j.1365-2362.1982.tb00947.x"},{"key":"116","doi-asserted-by":"crossref","unstructured":"(60) Deckelbaum RJ, et al.: Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis, 4: 225-231, 1984","DOI":"10.1161\/01.ATV.4.3.225"},{"key":"117","unstructured":"(61) Castelli WP: Cholesterol and lipids in the risk of coronary artery disease-The Framingham Heart Study. Can J Cardiol, (4 suppl) 5A-10A, 1988"},{"key":"118","unstructured":"(62) Murase T: Hpertriglyceridemia and low HDL-cholesterol in diabetes mellitus. In: Current Advances in Triglycerides and Atherosclerosis ed by Yamamoto A, et al., pp 135-139, Churchill Livingstone Japan, 1994"},{"key":"119","doi-asserted-by":"crossref","unstructured":"(63) McNamara JR, et al.: Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thuromb, 12: 1284-1290, 1992","DOI":"10.1161\/01.ATV.12.11.1284"},{"key":"120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0021-9150(94)90129-5","volume":"106","year":"1994","unstructured":"(64) Griffin BA, et al.: Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis, 106: 241-253, 1994","journal-title":"Atherosclerosis","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9150","issn-type":"print"},{"key":"121","doi-asserted-by":"publisher","unstructured":"(65) Austin MA, et al.: Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA, 260: 1917-1921, 1988","DOI":"10.1001\/jama.1988.03410130125037"},{"key":"122","doi-asserted-by":"crossref","unstructured":"(66) Chait A. et al.: Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype B. Am J Med, 94: 350-356, 1993","DOI":"10.1016\/0002-9343(93)90144-E"},{"key":"123","doi-asserted-by":"crossref","unstructured":"(67) Krauss RM: Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr Opin Lipidol, 5: 339-349, 1994","DOI":"10.1097\/00041433-199410000-00005"},{"key":"124","doi-asserted-by":"crossref","unstructured":"(68) Grundy SM and Vega GL: Two different views of the relationship of hypertriglyceridemia to coronary heart disease: implications for treatment. Arch Intern Med, 152: 28-34, 1992","DOI":"10.1001\/archinte.1992.00400130054004"},{"key":"125","doi-asserted-by":"crossref","unstructured":"(69) Marckmann P, et al.: Dietary effects on circadian fluctuation in human blood coagulation factor-VII and fibrinolysis. Atherosclerosis, 101: 225-234, 1993","DOI":"10.1016\/0021-9150(93)90119-F"},{"key":"126","doi-asserted-by":"crossref","unstructured":"(70) Hamsten A, et al.: Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med, 313: 1557-1563, 1987","DOI":"10.1056\/NEJM198512193132501"},{"key":"127","doi-asserted-by":"crossref","unstructured":"(71) Hamsten A, et al.: Hemostatic function in myocardial infarction. Br Heart J, 55: 58-66, 1986","DOI":"10.1136\/hrt.55.1.58"},{"key":"128","first-page":"331","volume":"13","year":"1987","unstructured":"(72) Juhan-Vague I, et al.: Relationships between plasma insulin, triglyceride, body mass index, and plasminogen activator inhibitor I, in diabetes. Metabolism, 13: 331-336, 1987","journal-title":"Metabolism Clinical and Experimental","ISSN":"https:\/\/id.crossref.org\/issn\/0026-0495","issn-type":"print"},{"key":"129","unstructured":"(73) Morishita E: All of the triglyceride. A disease with hypertriglycemia. The coagulation-fibrinolysis abnormality. Gendai Iryo, 28: 1861-1865, 1996 (in Japanese)"},{"key":"130","unstructured":"(74) Noma A: All of the triglyceride. Measurement and evaluation. Reference value in Japan. Gendai Iryo, 28: 1725-1727, 1996 (in Japanese)"},{"key":"131","unstructured":"(75) Tarui S: Annual report of research committee on primary hyperlipidemia (Ministry of Health and Welfare), p 17-28, 1987"},{"key":"132","unstructured":"(76) Tarui S: Annual report of research committee on primary hyperlipidemia (Ministry of Health and Welfare), Report of national surveillance, p 16-25, 1988"},{"key":"133","doi-asserted-by":"crossref","unstructured":"(77) Robertoson TL, et al.: Epidemiologic of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Coronary heart disease risk factors in Japan and Hawaii. Am J Cardiol, 39: 244-249, 1977","DOI":"10.1016\/S0002-9149(77)80198-7"},{"key":"134","unstructured":"(78) Yano K, et al.: A comparison of the 12-year mortality and predictive factors of coronary heart disease among Japanese men in Japan and Hawaii. Radiation Effects Research Foundation Technical Report 15-87; 1-19, 1988"},{"key":"135","doi-asserted-by":"crossref","unstructured":"(79) Albrink MJ and Man EB: Serum triglycerides in coronary artery disease. Arch Intern Med, 103: 4-8, 1959","DOI":"10.1001\/archinte.1959.00270010010002"},{"key":"136","unstructured":"(80) Criqui MH, et al.: Triglycerides and coronary heart disease mortality in the Lipid Research Clinics Follow-up Study. CVD Epidemiol Newsletter, 41: 13 (abst), 1987"},{"key":"137","doi-asserted-by":"crossref","unstructured":"(81) Fager G, et al.: Multivariate analysis of serum apolipoproteins and risk factors in relation to acute myocardial infaction. Arteriosclerosis, 1: 273-279, 1981","DOI":"10.1161\/01.ATV.1.4.273"},{"key":"138","doi-asserted-by":"publisher","unstructured":"(82) Schwandt P: Triglyceride-rich lipoproteins and atherosclerosis. Drugs, 40 (Supple 1): 38-41, 1990","DOI":"10.2165\/00003495-199000401-00009"},{"key":"139","doi-asserted-by":"crossref","unstructured":"(83) Mainard F, et al.: Comparative study of risk factors in patients undergoing coronary femoropopliteal artery by grafting. Br Heart J, 72: 542-547, 1994","DOI":"10.1136\/hrt.72.6.542"},{"key":"140","doi-asserted-by":"crossref","unstructured":"(84) Pocok SJ, et al.: Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischemic heart disease. Br Med J, 298: 998-1002, 1989","DOI":"10.1136\/bmj.298.6679.998"},{"key":"141","doi-asserted-by":"crossref","unstructured":"(85) Manninen V, et al.: Relation between baseline lipid and lipoprotein value and the incidence of coronary heart disease in the Helsinki Heart Study. Am J Cardiol, 63: 42H-47H, 1989","DOI":"10.1016\/0002-9149(89)90115-X"},{"key":"142","doi-asserted-by":"crossref","unstructured":"(86) Simons LA: Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries. Am J Cardiol, 57: 5G-10G, 1986","DOI":"10.1016\/0002-9149(86)90659-4"},{"key":"143","doi-asserted-by":"crossref","unstructured":"(87) Study Group of the European Atherosclerosis Society: The recognition and management of hyperlipidemia in adults. A policy statement of the European Atherosclerosis Society: Eur Heart J, 9: 571-600, 1988","DOI":"10.1093\/oxfordjournals.eurheartj.a062547"},{"key":"144","unstructured":"(88) Prevention of coronary heart disease: Scientific background and new clinical guidelines. Recommendations of the European Atherosclerosis Society prepared by the International Task Force for Prevention of Coronary Heart Disease. Nutr Metab Cardiovas Dis, 2: 113-156, 1992"},{"key":"145","doi-asserted-by":"crossref","unstructured":"(89) Stein Y: Comparison of European and USA guidelines for prevention of coronary heart disease. Atherosclerosis, 110 (Suppl): S41-S44, 1994","DOI":"10.1016\/0021-9150(94)05376-T"},{"key":"146","doi-asserted-by":"crossref","unstructured":"(90) Barbir M, et al.: High prevalence of hypertriglyceridemia and apolioprotein abnormalities in coronary artery disease. Br Heart J, 60: 397-403, 1988","DOI":"10.1136\/hrt.60.5.397"},{"key":"147","doi-asserted-by":"publisher","unstructured":"(91) Kannel WB: Role of lipids in the development of brain infarction. The Framingham Study. Stroke, 5: 679-685, 1974","DOI":"10.1161\/01.STR.5.6.679"},{"key":"148","first-page":"1105","volume":"15","year":"1984","unstructured":"(92) Dyken ML, et al.: Risk factors for stroke. Stroke, 15: 1105-1111, 1984","journal-title":"Stroke","ISSN":"https:\/\/id.crossref.org\/issn\/0039-2499","issn-type":"print"},{"key":"149","doi-asserted-by":"crossref","unstructured":"(93) Agner E and Hansen PF: Fasting serum cholesterol and triglycerides in a ten year prospective study in old age. Acta Med Scand, 214: 33-41, 1983","DOI":"10.1111\/j.0954-6820.1983.tb08567.x"},{"key":"150","doi-asserted-by":"publisher","unstructured":"(94) R&ouml;ssner S, et al.: Dyslipoproteimia in patients with ischemic cerebrovascular disease. Atherosclerosis, 30: 199-209, 1978","DOI":"10.1016\/0021-9150(78)90046-1"},{"key":"151","doi-asserted-by":"publisher","unstructured":"(95) Daniels SR, et al.: Cerebrovascular arteriopathy (arteriosclerosis) and ischemic childhood stroke. Stroke, 13: 360-365, 1982","DOI":"10.1161\/01.STR.13.3.360"},{"key":"152","doi-asserted-by":"publisher","unstructured":"(96) Mathew NT, et al.: Hyperlipoproteinemia in occlusive cerebrovascular disease. JAMA, 232: 262-266, 1975","DOI":"10.1001\/jama.232.3.262"},{"key":"153","doi-asserted-by":"publisher","unstructured":"(97) Pedro-Botet J, et al.: Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein (a), triglyceride-rich lipoproteins, and apolipoproteins E polymorphism. Stroke, 23: 1556-1562, 1992","DOI":"10.1161\/01.STR.23.11.1556"},{"key":"154","doi-asserted-by":"publisher","unstructured":"(98) Rogers RI, et al.: Reducing hypertriglyceridemia in elderly patients with cerebrovascular disease stabilizes or improves cognition and cerebral perfusion. Angiology, 40: 260-269, 1989","DOI":"10.1177\/000331978904000404"},{"key":"155","doi-asserted-by":"publisher","unstructured":"(1) Miller GJ and Miller NE: Plasma high-density-lipoprotein concentration and development of ischaemic heart disease. Lancet, 1: 16-19, 1975","DOI":"10.1016\/S0140-6736(02)95332-8"},{"key":"156","doi-asserted-by":"crossref","unstructured":"(2) Gordon T, Castelli WP, Hjortland MC, Kannel WB, and Dawber TR: High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med, 62: 707-714, 1977","DOI":"10.1016\/0002-9343(77)90874-9"},{"key":"157","doi-asserted-by":"publisher","unstructured":"(3) Wiklund O, Wilhelmsen L, Elmfeldt D, Wedel H, Valek J, and Gustafson A: Alpha-lipoprotein cholesterol concentration in relation to subsequent myocardial infarction in hypercholesterolemic men. Atherosclerosis, 37: 47-53, 1980","DOI":"10.1016\/0021-9150(80)90092-1"},{"key":"158","doi-asserted-by":"crossref","unstructured":"(4) Pocock SJ, Shaper AG, and Phillips AN: Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease. Br Med J, 298: 998-1002, 1989","DOI":"10.1136\/bmj.298.6679.998"},{"key":"159","doi-asserted-by":"crossref","unstructured":"(5) Goldbourt U and Medalie JH: High density lipoprotein cholesterol and incidence of coronary heart disease. The Israeli Ischemic Heart Disease Study. Am J Epidemiol, 109: 296-308, 1979","DOI":"10.1093\/oxfordjournals.aje.a112683"},{"key":"160","doi-asserted-by":"crossref","unstructured":"(6) Badimon JJ, Badimon L, and Fuster V: Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest, 85: 1234-1241, 1990","DOI":"10.1172\/JCI114558"},{"key":"161","doi-asserted-by":"publisher","unstructured":"(7) Castro GR and Fielding CJ: Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry, 27: 25-29, 1988","DOI":"10.1021\/bi00401a005"},{"key":"162","doi-asserted-by":"publisher","unstructured":"(8) Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, and Clift SM: Inhibition of early atherosclerosis in transgenic mice by human apolipoprotein Al. Nature, 353: 265-267, 1991","DOI":"10.1038\/353265a0"},{"key":"163","doi-asserted-by":"crossref","unstructured":"(9) Glomset JA: The plasma lecithin: cholesterol acyltransferase reaction. J Lipid Res, 9: 155-167, 1968","DOI":"10.1016\/S0022-2275(20)43114-1"},{"key":"164","unstructured":"(10) Breslow JL: Familial disorders of high-density lipoprotein metabolism. In: The Metabolic and Molecular Bases of Inherited Disease. ed by Scriver CR, Beaudet AL, Sly WS, Valle D, 7th ed, pp 2031-2052, McGraw Hill, 1995"},{"key":"165","doi-asserted-by":"crossref","unstructured":"(11) Matsson FH and Grundy SM: Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins. J Lipid Res, 26: 194-202, 1985","DOI":"10.1016\/S0022-2275(20)34389-3"},{"key":"166","doi-asserted-by":"crossref","unstructured":"(12) Shepherd J, Packard CJ, Patsch JR, Gotto AM Jr, and Taunton OD: Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I. J Clin Invest, 61: 1582-1592, 1978","DOI":"10.1172\/JCI109078"},{"key":"167","doi-asserted-by":"crossref","unstructured":"(13) Vega GL, Groszek E, Wolf R, and Grundy SM: Influence of polyunsaturated fats on composition of plasma lipoproteins and apolipoproteins. J Lipid Res, 23: 811-822, 1982","DOI":"10.1016\/S0022-2275(20)38083-4"},{"key":"168","doi-asserted-by":"crossref","unstructured":"(14) Sarkkinen ES, Uusitupa MIJ, Pietinen P, Aro A, Ahola I, Penttil&auml; I, Kervinen K, and Kesaniemi YA: Long-term effects of three fat-modified diets in hypercholesterolaemic subjects. Atherosclerosis, 105: 9-23, 1994","DOI":"10.1016\/0021-9150(94)90003-5"},{"key":"169","doi-asserted-by":"crossref","unstructured":"(15) Gordon T, Kannel WB, Castelli WP, and Dawber TR: Lipoproteins, cardiovascular disease and death. The Framingham Study. Arch Intern Med, 141: 1128-1131, 1981","DOI":"10.1001\/archinte.1981.00340090024008"},{"key":"170","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/jama.1986.03380200073024","volume":"256","year":"1986","unstructured":"(16) Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, and Kannel WB: Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA, 256: 2835-2838, 1986","journal-title":"JAMA The Journal of the American Medical Association","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"171","doi-asserted-by":"crossref","unstructured":"(17) Abbott RD, Wilson PWF, Kannel WB, and Castelli WP: High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis, 8: 207-211, 1988","DOI":"10.1161\/01.ATV.8.3.207"},{"key":"172","doi-asserted-by":"publisher","unstructured":"(18) Stamler J, Wentworth D, and Neaton JD: Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356, 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA, 256: 2823-2828, 1986","DOI":"10.1001\/jama.256.20.2823"},{"key":"173","doi-asserted-by":"publisher","unstructured":"(19) Gordon DJ, Probstfeld JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, and Tyroler HA: High-density lipoprotein cholesterol and cardiovascular disease; four prospective American studies. Circulation, 79: 8-15, 1989","DOI":"10.1161\/01.CIR.79.1.8"},{"key":"174","doi-asserted-by":"crossref","unstructured":"(20) Miller M and Kwiterovich PO, Jr: Isolated low HDL-cholesterol as an important risk factor for coronary heart disease. Eur Heart J, 11 (Suppl H): 9-14, 1990","DOI":"10.1093\/eurheartj\/11.suppl_H.9"},{"key":"175","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1161\/01.CIR.89.6.2533","volume":"89","year":"1994","unstructured":"(21) Kitamura A, Iso H, Naito Y, Iida M, Konishi M, Folsom AR, Sato S, Kiyama M, Nakamura M, Sankai T, Shimamoto T, and Komachi Y: High-density lipoprotein cholesterol and premature coronary heart disease in Urban Japanese men. Circulation, 89: 2533-2539, 1994","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"176","doi-asserted-by":"crossref","unstructured":"(22) Kukita H, Imamura Y, Hamada M, Joh T, and Kokubu T: Plasma lipids and lipoproteins in Japanese male patients with coronary artery disease and in their relatives. Atherosclerosis, 42: 21-29, 1982","DOI":"10.1016\/0021-9150(82)90122-8"},{"key":"177","doi-asserted-by":"publisher","unstructured":"(24) Noma A, Matsushita S, Komori T, Abe K, Okabe H, Kuramoto K, and Murakami M: High and low density lipoprotein cholesterol in myocardial and cerebral infarction. Atherosclerosis, 32: 327-331, 1979","DOI":"10.1016\/0021-9150(79)90176-X"},{"key":"178","doi-asserted-by":"crossref","unstructured":"(25) Fujinami T, Hirata H, Hayano J, Ohte N, Kohketsu M, and Hashimoto T: Coronary risk factors in angiographically defined patients with chest pain. Jpn J Med, 29: 462-468, 1990","DOI":"10.2169\/internalmedicine1962.29.462"},{"key":"179","doi-asserted-by":"publisher","unstructured":"(26) Hirobe K, Matsuzawa Y, Ishikawa K, Tarui S, Yamamoto A, Nambu S, and Fujimoto K: Coronary artery disease in heterozygous familial hypercholesterolemia. Atherosclerosis, 44: 201-210, 1982","DOI":"10.1016\/0021-9150(82)90114-9"},{"key":"180","doi-asserted-by":"crossref","unstructured":"(27) Handa K, Sasaki J, Saku K, Kono S, and Arakawa K: Alcohol consumption, serum lipids and severity of angiographically determined coronary artery disease. Am J Cardiol, 65: 287-289, 1990","DOI":"10.1016\/0002-9149(90)90289-D"},{"key":"181","doi-asserted-by":"publisher","unstructured":"(28) Murai A, Tanaka T, Miyahara T, and Kameyama M: Lipoprotein abnormalities in the pathogenesis of cerebral infarction and transient ischemic attack. Stroke, 12: 167-172, 1981","DOI":"10.1161\/01.STR.12.2.167"},{"key":"182","unstructured":"(29) Omata S, Yoshida M, Miyatake T, Sakamoto Y, and Sakurabayashi I: Decreased HDL cholesterol in patients with cerebrovascular disease. Acta Neurol Scand (Suppl), 72: 460-461, 1979"},{"key":"183","doi-asserted-by":"publisher","unstructured":"(31) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA, 269: 3015-3023, 1993","DOI":"10.1001\/jama.269.23.3015"},{"key":"184","first-page":"1329","volume":"89","year":"1994","unstructured":"(32) National Cholesterol Education Program: Second Report of the Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation, 89: 1329-1445, 1994","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"185","doi-asserted-by":"crossref","unstructured":"(33) Current state of and recent trends in serum lipid levels in the general Japanese population. Research Committee on Serum Lipid Level Survey 1990 in Japan. J Atheroscler Thromb, 2: 122-132, 1996","DOI":"10.5551\/jat1994.2.122"},{"key":"186","unstructured":"(34) Yamashita S: Pathogenesis and pathophysiology of familial hyperalphalipoproteinemia with special reference to abnormalities of CETP. Igaku No Ayumi, 172: 291-296, 1995 (in Japanese)"},{"key":"187","doi-asserted-by":"crossref","unstructured":"(35) Hirano K, Yamashita S, Sakai N, Arai T, Yoshida Y, Nozaki S, Kameda-Takemura K, and Matsuzawa Y: Molecular defect and atherogenicity in cholesteryl ester transfer protein deficiency. Ann N Y Acad Sci, 748: 599-602, 1995","DOI":"10.1111\/j.1749-6632.1994.tb17370.x"},{"key":"188","doi-asserted-by":"crossref","unstructured":"(36) Hirano K, Yamashita S, Kuga Y, Sakai N, Nozaki S, Kihara S, Arai T, Yanagi K, Takami S, Menju M, Ishigami M, Yoshida Y, Kameda-Takumura K, Hayashi K, and Matsuzawa Y: Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler Thromb Vasc Biol, 15: 1849-1856, 1995","DOI":"10.1161\/01.ATV.15.11.1849"},{"key":"189","doi-asserted-by":"crossref","unstructured":"(37) Hirano K, Yamashita S, Nakajima N, Arai T, Maruyama T, Yoshida Y, Ishigami M, Sakai N, Kameda-Takemura K, and Matsuzawa Y: Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan; Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler Thromb Vasc Biol, 17: 1053-1059, 1997","DOI":"10.1161\/01.ATV.17.6.1053"},{"key":"190","unstructured":"(38) Fushimi E, Takahashi T, Sekiguchi N, Watanabe H, Hayashi M, Ikeda Y, and Nakajima N: Clinical studies in atherosclerosis with HDL hyperlipidemia. Carotid angiography and pulse wave velocity. Jpn Circ J, 61 (Suppl I): 482 (abst), 1997 (in Japanese)"},{"key":"191","doi-asserted-by":"crossref","unstructured":"(39) Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, and Tall AR: Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest, 97: 2917-2923, 1996","DOI":"10.1172\/JCI118751"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/9\/1\/9_1_1\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T09:49:25Z","timestamp":1637833765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/9\/1\/9_1_1\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"references-count":191,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.9.1","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002]]}}}